Theriva Biologics Inc (TOVX)
0.35
-0.05
(-13.37%)
USD |
NYAM |
May 10, 15:51
Theriva Biologics 1 Year Total Returns (Daily): -44.32% for May 9, 2024
1 Year Total Returns (Daily) Chart
Historical 1 Year Total Returns (Daily) Data
Date | Value |
---|---|
May 09, 2024 | -44.32% |
May 08, 2024 | -42.68% |
May 07, 2024 | -43.13% |
May 06, 2024 | -45.58% |
May 03, 2024 | -37.06% |
May 02, 2024 | -37.61% |
May 01, 2024 | -36.47% |
April 30, 2024 | -36.11% |
April 29, 2024 | -33.33% |
April 26, 2024 | -34.45% |
April 25, 2024 | -40.99% |
April 24, 2024 | -45.79% |
April 23, 2024 | -45.69% |
April 22, 2024 | -40.78% |
April 19, 2024 | -41.36% |
April 18, 2024 | -39.12% |
April 17, 2024 | -41.22% |
April 16, 2024 | -40.99% |
April 15, 2024 | -40.68% |
April 12, 2024 | -31.89% |
April 11, 2024 | -35.07% |
April 10, 2024 | -35.29% |
April 09, 2024 | -33.61% |
April 08, 2024 | -32.45% |
April 05, 2024 | -35.99% |
Date | Value |
---|---|
April 04, 2024 | -37.68% |
April 03, 2024 | -38.96% |
April 02, 2024 | -37.00% |
April 01, 2024 | -36.51% |
March 28, 2024 | -27.85% |
March 27, 2024 | -23.10% |
March 26, 2024 | -25.95% |
March 25, 2024 | -20.22% |
March 22, 2024 | -16.14% |
March 21, 2024 | -30.36% |
March 20, 2024 | -17.71% |
March 19, 2024 | -41.97% |
March 18, 2024 | -40.79% |
March 15, 2024 | -45.45% |
March 14, 2024 | -47.71% |
March 13, 2024 | -41.52% |
March 12, 2024 | -37.84% |
March 11, 2024 | -34.76% |
March 08, 2024 | -41.25% |
March 07, 2024 | -46.86% |
March 06, 2024 | -43.66% |
March 05, 2024 | -42.71% |
March 04, 2024 | -43.65% |
March 01, 2024 | -42.79% |
February 29, 2024 | -48.33% |
Total Return Definition
The Total return is the change in price over a specific period of time that includes dividends and distributions paid.
1 Year Total Returns (Daily) Range, Past 5 Years
-94.13%
Minimum
May 31 2019
206.1%
Maximum
Mar 12 2021
-33.79%
Average
-48.07%
Median
Dec 02 2019
1 Year Total Returns (Daily) Benchmarks
NovaBay Pharmaceuticals Inc | -90.89% |
Palatin Technologies Inc | 5.38% |
iBio Inc | -91.38% |
Oragenics Inc | -61.67% |
Nanoviricides Inc | 42.97% |